|
|
|
Insider
Information: |
Satter Muneer A |
Relationship: |
Director, 10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
60,789,542 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$74,997,677 |
|
|
Total
Shares |
60,789,542 |
|
|
Total
Value |
$74,997,677 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
DFC Global Corp |
DLLR |
Director |
|
0 |
2005-01-27 |
1,193,504 |
Premium* |
|
HeartWare International Inc |
HTWR |
10% Owner |
2008-04-14 |
0 |
2008-07-11 |
25,150,000 |
Premium* |
|
Akebia Therapeutics, Inc. |
AKBA |
Director |
2014-03-25 |
0 |
2017-07-05 |
3,037,042 |
Premium* |
|
Immunic Inc |
IMUX |
Director, 10% Owner |
|
0 |
2018-09-17 |
0 |
Premium* |
|
Eledon Pharmaceuticals Ord Shs |
ELDN |
10% Owner |
2014-09-22 |
0 |
2014-09-22 |
1,771,688 |
Premium* |
|
Aadi Bioscience, Inc |
AADI |
Director, 10% Owner |
2017-03-15 |
0 |
2019-01-10 |
5,621,835 |
Premium* |
|
Aileron Therapeutics Inc |
ALRN |
See Remarks, Director |
2017-07-05 |
0 |
2021-01-08 |
16,609,449 |
Premium* |
|
Annexon, Inc. |
ANNX |
Director, 10% Owner |
2020-07-28 |
0 |
2023-12-26 |
7,406,024 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DLLR |
DFC Global Corp |
Director |
|
2005-01-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,193,504 |
|
- |
|
HTWR |
HeartWare International I... |
10% Owner |
|
2008-04-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
31,750,000 |
|
- |
|
HTWR |
HeartWare International I... |
10% Owner |
|
2008-04-14 |
4 |
B |
$0.31 |
$314,400 |
I/I |
1,000,000 |
6,000,000 |
1.5 |
- |
|
HTWR |
HeartWare International I... |
10% Owner |
|
2008-07-11 |
4 |
B |
$0.48 |
$2,524,725 |
I/I |
5,250,000 |
150,000 |
1.5 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
Director |
|
2014-03-25 |
4 |
A |
$0.00 |
$0 |
I/I |
1,441,265 |
1,441,265 |
0 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
Director |
|
2014-03-25 |
4 |
B |
$17.00 |
$1,552,015 |
I/I |
91,295 |
1,532,560 |
2.1 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2014-04-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
142,117 |
|
- |
|
IMUX |
Immunic Inc |
Director |
|
2014-04-23 |
4 |
A |
$0.00 |
$0 |
I/I |
6,140,402 |
6,282,519 |
0 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2014-04-23 |
4 |
B |
$12.00 |
$4,331,592 |
I/I |
360,966 |
6,643,485 |
2.25 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2014-06-02 |
4 |
B |
$12.45 |
$98,355 |
I/I |
7,900 |
6,651,385 |
2.25 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2014-06-03 |
4 |
B |
$13.61 |
$92,456 |
I/I |
6,600 |
6,657,985 |
2.25 |
- |
|
ELDN |
Eledon Pharmaceuticals Or... |
10% Owner |
|
2014-09-22 |
4 |
B |
$15.00 |
$2,250,000 |
I/I |
150,000 |
1,771,688 |
1.5 |
- |
|
ELDN |
Eledon Pharmaceuticals Or... |
10% Owner |
|
2014-09-22 |
4 |
A |
$0.00 |
$0 |
I/I |
1,621,688 |
1,621,688 |
0 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2014-10-08 |
4 |
B |
$17.50 |
$1,300,005 |
I/I |
74,286 |
6,732,277 |
2.25 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
Director |
|
2014-11-12 |
4 |
B |
$10.85 |
$59,515 |
I/I |
5,000 |
1,537,560 |
2.1 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
Director |
|
2014-11-13 |
4 |
B |
$11.56 |
$57,800 |
I/I |
5,000 |
1,542,560 |
2.1 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
Director |
|
2014-11-14 |
4 |
B |
$11.91 |
$59,550 |
I/I |
5,000 |
1,547,560 |
2.1 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
Director |
|
2014-11-17 |
4 |
B |
$12.94 |
$64,700 |
I/I |
5,000 |
1,552,560 |
2.1 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
Director |
|
2014-11-18 |
4 |
B |
$13.84 |
$69,200 |
I/I |
5,000 |
1,557,560 |
2.1 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
Director |
|
2014-11-19 |
4 |
B |
$14.85 |
$74,250 |
I/I |
5,000 |
1,562,560 |
2.1 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
Director |
|
2014-11-20 |
4 |
B |
$14.70 |
$73,500 |
I/I |
5,000 |
1,567,560 |
2.1 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
Director |
|
2014-11-21 |
4 |
B |
$14.73 |
$73,650 |
I/I |
5,000 |
1,572,560 |
2.1 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
Director |
|
2014-11-24 |
4 |
B |
$13.88 |
$69,400 |
I/I |
5,000 |
1,577,560 |
2.1 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
Director |
|
2014-11-25 |
4 |
B |
$13.18 |
$65,900 |
I/I |
5,000 |
1,582,560 |
2.1 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
Director |
|
2015-04-22 |
4 |
B |
$8.25 |
$3,465,000 |
I/I |
420,000 |
2,002,560 |
2.1 |
- |
|
91 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|